Addus HomeCare (NASDAQ:ADUS – Get Free Report) had its target price boosted by investment analysts at Royal Bank Of Canada from $134.00 to $141.00 in a report released on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada‘s price objective would indicate a potential upside of 13.37% from the company’s current price.
Other analysts have also issued reports about the stock. Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 7th. Raymond James Financial set a $137.00 target price on Addus HomeCare in a research report on Monday, September 28th. Weiss Ratings upgraded Addus HomeCare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday. Barclays upped their target price on Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a research note on Wednesday, November 4th. Finally, Truist Financial increased their price target on Addus HomeCare from $135.00 to $148.00 and gave the stock a “buy” rating in a report on Thursday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and an average price target of $137.11.
Read Our Latest Research Report on Addus HomeCare
Addus HomeCare Trading Up 1.1%
Shares of ADUS traded up $1.37 during midday trading on Monday, hitting $124.37. The stock had a trading volume of 17,028 shares, compared to its average volume of 235,557. The stock’s 50 day moving average is $118.39 and its 200 day moving average is $107.25. The firm has a market cap of $2.32 billion, a PE ratio of 20.64, a price-to-earnings-growth ratio of 1.62 and a beta of 0.75. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.64. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $131.59.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The firm had revenue of $387.74 million during the quarter, compared to analysts’ expectations of $388.72 million. During the same period in the previous year, the company earned $1.56 EPS. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. As a group, analysts forecast that Addus HomeCare will post 6.41 EPS for the current fiscal year.
Insider Buying and Selling at Addus HomeCare
In other news, EVP David Tucker sold 14,850 shares of the business’s stock in a transaction on Friday, November 6th. The shares were sold at an average price of $124.75, for a total transaction of $1,852,537.50. Following the completion of the sale, the executive vice president directly owned 8,073 shares of the company’s stock, valued at approximately $1,007,106.75. The trade was a 64.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brian Poff sold 6,644 shares of the business’s stock in a transaction on Friday, November 6th. The shares were sold at an average price of $124.72, for a total transaction of $828,639.68. Following the sale, the executive vice president directly owned 57,048 shares of the company’s stock, valued at $7,115,026.56. This represents a 10.43% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 141,894 shares of company stock valued at $17,536,266. 4.10% of the stock is owned by company insiders.
Institutional Investors Weigh In On Addus HomeCare
Several large investors have recently added to or reduced their stakes in ADUS. Apis Capital Advisors LLC boosted its position in Addus HomeCare by 47.6% in the 3rd quarter. Apis Capital Advisors LLC now owns 124,000 shares of the company’s stock valued at $13,707,000 after buying an additional 40,000 shares during the period. First National Bank of Omaha increased its position in shares of Addus HomeCare by 8.9% during the third quarter. First National Bank of Omaha now owns 6,344 shares of the company’s stock worth $701,000 after acquiring an additional 519 shares during the period. Pathstone Holdings LLC increased its position in shares of Addus HomeCare by 16.3% during the third quarter. Pathstone Holdings LLC now owns 5,873 shares of the company’s stock worth $649,000 after acquiring an additional 823 shares during the period. First Trust Advisors LP increased its position in shares of Addus HomeCare by 21.9% during the third quarter. First Trust Advisors LP now owns 39,432 shares of the company’s stock worth $4,359,000 after acquiring an additional 7,084 shares during the period. Finally, Private Wealth Asset Management LLC purchased a new position in shares of Addus HomeCare during the third quarter worth approximately $187,000. 95.35% of the stock is owned by hedge funds and other institutional investors.
Addus HomeCare Company Profile
Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- Sandisk’s Sell-Off May Be Losing Steam, But the Biggest Risk Still Looms
- Meta’s Access to Capital Remains Strong, But Borrowing Is Becoming More Expensive
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
